Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bridgebio Pharma Inc
(NQ:
BBIO
)
25.82
+0.36 (+1.39%)
Streaming Delayed Price
Updated: 12:35 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bridgebio Pharma Inc
< Previous
1
2
3
4
5
6
Next >
What's Going On With BridgeBio Pharma Stock On Monday?
March 04, 2024
BridgeBio Pharma partners with Bayer on acoramidis for ATTR-CM in Europe. $310 million deal, FDA application accepted.
Via
Benzinga
Exposures
Product Safety
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?
March 04, 2024
BridgeBio will receive a tiered royalty on sales that begins at the low-30% range.
Via
Investor's Business Daily
Recap: BridgeBio Pharma Q4 Earnings
February 22, 2024
Via
Benzinga
Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday
February 15, 2024
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
2 Biotechs That Could Get Bought Out in 2024
January 03, 2024
These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason.
Via
The Motley Fool
The Latest Analyst Ratings for BridgeBio Pharma
October 24, 2023
Via
Benzinga
4 Analysts Have This to Say About BridgeBio Pharma
August 14, 2023
Via
Benzinga
3 Groundbreaking Biotech Stocks to Invest in Now
January 29, 2024
These are several biotech companies for investors seeking unique opportunities for great returns within the industry.
Via
InvestorPlace
7 Exciting Stocks Poised for Explosive Growth in Key Sectors
January 22, 2024
These stocks to buy for growth already have a strong growth story. If they reach their potential investors could see some dynamic returns.
Via
InvestorPlace
3 Russell 2000 Stocks That Are About to Get Absolutely Crushed
December 18, 2023
The Russell 2000 has only begun closing its wide gap with other indices, but investors should be weary of these three stocks to sell.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
Via
Benzinga
Why Is Biomarin & BridgeBio Pharma Rival Lumos Pharma Stock Trading Higher Today?
November 08, 2023
Lumos Pharma Inc (NASDAQ: LUMO) announced that topline results from its Phase 2 OraGrowtH210 dose-finding trial and its Phase 2 OraGrowtH212 Pharmacokinetic/Pharmacodynamic (PK/PD) trial met all...
Via
Benzinga
Expert Ratings for BridgeBio Pharma
July 18, 2023
Via
Benzinga
Rare Disease Player BridgeBio Pharma's Upside Potential Is Significant According to Citi Analyst - Here's Why
November 07, 2023
Citi initiated coverage on BridgeBio Pharma Inc (NASDAQ: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, noting an optimistic outlook on the stock.
Via
Benzinga
Why BridgeBio Pharma Was a Healthy Stock Today
October 24, 2023
One of the best-performing biotechs on the stock market this year gets a bullish nod from a researcher.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Via
Benzinga
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
September 28, 2023
Raymond James initiated coverage on BioMarin Pharmaceuticals Inc (NASDAQ: BMRN) with a Market Perform rating, noting sparsity in
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
Via
Benzinga
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
September 13, 2023
These three pharma stocks could be driven higher amidst future revenue prospects as they report to investors positive clinical developments.
Via
InvestorPlace
What's Going On With BridgeBio Pharma Stock Today?
August 28, 2023
BridgeBio Pharma Inc (NASDAQ: BBIO) announced the presentation of detailed results from its Phase 3 ATTRibute-CM study of acoramidis for ATTR-CM at the
Via
Benzinga
Pfizer Was First In Treating This Heart Disease. Why BridgeBio Could Be Better.
August 28, 2023
The companies are expected to compete in a genetic heart disease beginning in late 2024.
Via
Investor's Business Daily
Wall Street Thinks BridgeBio Pharma Could Rise Over 40% -- But Will It?
August 09, 2023
Its potential upcoming drug launch might not be enough.
Via
The Motley Fool
7 A-Rated Stocks for Your August Buy List
August 03, 2023
August is shaping up to be a great month for the stock market. Now you just need to make sure you own these A-rated stocks.
Via
InvestorPlace
Could This Stock Be the Next Biotech Buyout?
July 31, 2023
A buyout deal recently pushed Reata Pharmaceuticals stock 53% higher in a single trading session, leading investors to wonder who's next.
Via
The Motley Fool
Why Shares of BridgeBio Pharma Skyrocketed This Week
July 21, 2023
The biotech company saw strong results in a phase 3 trial.
Via
The Motley Fool
Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review
July 21, 2023
But all the major indexes are at or near 15-month highs.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
July 18, 2023
Via
Benzinga
Crude Oil Falls; GreenPower Motor Company Shares Spike Higher
July 17, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 0.25% on Monday. The Dow traded up 0.25% to 34,596.04 while the NASDAQ rose 0.92% to 14,243.64. The S&P 500, also rose,...
Via
Benzinga
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks
July 17, 2023
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%.
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
July 17, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.